Prosecution Insights
Prosecution Insights
151 pending office actions • 60 clients • 137 examiners • 76 art units • 0 of 151 (0%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 74 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 74 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 4 (3%) |
| §101 + other | 21 (14%) |
| §103 only | 36 (24%) |
| §102 only | 2 (1%) |
| §112 only | 14 (9%) |
| Double-patenting only | 4 (3%) |
| Double-patenting + other | 7 (5%) |
| Multi-statute (no §101) | 62 (41%) |
| No statute on record | 1 (1%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BALLARD, KIMBERLY | 3 | 53.9% | +48.0% |
| IANNUZO, NATALIE NMN | 2 | 13.5% | +83.3% |
| ZOU, NIANXIANG | 2 | 64.0% | +24.4% |
| LANNU, JOSHUA DARYL DEANON | 2 | 82.4% | +23.7% |
| BUNNER, BRIDGET E | 2 | 64.4% | +20.1% |
| GILL, RACHEL B | 2 | 65.5% | +27.9% |
| REGA, KYLE THOMAS | 2 | 61.8% | +40.7% |
| ROSSI, JULIA ANNE LORRAIN | 2 | 47.1% | +60.0% |
| BAUSCH, SARAE L | 2 | 29.6% | +44.4% |
| DABKOWSKI, ERINNE R | 2 | 55.9% | +69.2% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18002125 | Containment, Treatment, and Removal of Aerosolized Viral Contamination | LANNU, JOSHUA DARYL DEANON | 20d |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17907697 | Synthetic Soluble Receptor Mimics and Methods of Use for Treatment of COVID-19 | ROSSI, JULIA ANNE LORRAIN | 167d overdue |
| 17907121 | Targeted Destruction of Viral RNA by CRISPR-Cas13 | HILL, KEVIN KAI | 145d overdue |
| 18064482 | LARGE AND SMALL T ANTIGENS OF MERKEL CELL POLYOMAVIRUS, NUCLEIC ACID CONSTRUCTS AND VACCINES MADE THEREFROM, AND METHODS OF USING SAME | FOLEY, SHANON A | 138d overdue |
| 18458214 | Recombinant Fusion Proteins Targeting P-selectin, and Methods of Use Thereof for Treating Diseases and Disorders | ALLEN, MARIANNE P | 104d overdue |
| 18248166 | METHOD FOR DETERMINING WHETHER OR NOT VIRUS-NEUTRALIZING ANTIBODIES ARE PRESENT AND IN VITRO METHOD FOR SCREENING COMPOUNDS FOR THEIR ABILITY TO NEUTRALIZE A VIRUS | GRIZER, CASSANDRA SENN | 84d overdue |
| 17425384 | NOVEL BIOMARKERS AND DIAGNOSTIC PROFILES FOR PROSTATE CANCER | CLOW, LORI A | 66d overdue |
| 15733794 | NONWOVEN HEMP HURD-BASED MATERIALS | SINGH-PANDEY, ARTI R | 50d overdue |
| 18588643 | MAGE-A VACCINES AND METHODS OF TREATMENT USING THE SAME | EDGINGTONGIORDANO, FRANCESCA | 37d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17907697 | Synthetic Soluble Receptor Mimics and Methods of Use for Treatment of COVID-19 | ROSSI, JULIA ANNE LORRAIN | 167d overdue |
| 18503487 | Vaccines For Human Papilloma Virus And Methods For Using The Same | ZOU, NIANXIANG | 138d overdue |
| 18251620 | DNA ENCODED NANOPARTICLES AND METHOD OF USE THEREOF AS A CORONAVIRUS DISEASE 2019 (COVID-19) VACCINE | GILL, RACHEL B | 11d overdue |
| 18042796 | INTRADERMAL MERS-CoV VACCINE | GILL, RACHEL B | 12d |
| 18002125 | Containment, Treatment, and Removal of Aerosolized Viral Contamination | LANNU, JOSHUA DARYL DEANON | 20d |
| 16755198 | A Cell-Based Seeding Assay for Huntingtin Aggregation | BALLARD, KIMBERLY | 20d |
| 17317057 | DETECTION OF AUTOREACTIVE FECAL IMMUNOGLOBULIN A (IGA) FOR DIAGNOSIS OF LUPUS | BALLARD, KIMBERLY | 34d |
| 17283315 | Selective Binding and Aggregation of Human Keratin in the Skin Barrier Using Human Filaggrin Subdomains SD67 and SD150 | DABKOWSKI, ERINNE R | 57d |
| Art Unit | Apps |
|---|---|
| 3791 | 9 |
| 1672 | 7 |
| 1671 | 6 |
| 3792 | 4 |
| 1653 | 4 |
| 1636 | 4 |
| 1643 | 3 |
| 1647 | 3 |
| 1631 | 3 |
| 1632 | 3 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19286887 | APPROACHES FOR THE SELECTIVE DEPLETION OF PLA2R-SPECIFIC ANTIBODIES | Astero Biopharma LLC | DENT, ALANA HARRIS | 1643 | §101 | Final Rejection | — | Pending | Jul 31, 2025 |
| 19191824 | KNOTLESS SUTURE ANCHOR WITH RE-TENSION FEATURES | Aevumed, Inc. | SEVERSON, RYAN J | DP | Non-Final OA | — | Pending | Apr 28, 2025 | |
| 18981897 | SYSTEM AND METHOD FOR MODIFYING A LIVING ENVIRONMENT TO ASSIST IN FALL PREVENTION | Myraina, LLC | CHEN, PATRICK C | 2842 | §103§112 | Non-Final OA | — | Pending | Dec 16, 2024 |
| 18982230 | SYSTEM AND METHOD FOR OPERATING SAFETY LIGHTING WHEN A FALL IS PREDICTED OR DETECTED | Myraina, LLC | PREVIL, DANIEL | 2685 | §103 | Final Rejection | — | Pending | Dec 16, 2024 |
| 18971619 | APPARATUS, SYSTEM AND METHOD OF PROVIDING A FFF PRINTING NOZZLE | 3D Print Innovations, LLC | TSUI, YUNG-SHENG M | 1743 | §102§112 | Final Rejection | — | Pending | Dec 06, 2024 |
| 18939015 | SYSTEM AND METHOD FOR TETHERED UNMANNED AERIAL VEHICLE TAKEOFF, LANDING, AND STORAGE | Dragonfly Pictures, Inc. | BAAJOUR, SHAHIRA | 3666 | §103 | Non-Final OA | 41d | Pending | Nov 06, 2024 |
| 18860838 | AN EFFICIENT APPROACH TO OPTIMAL EXPERIMENTAL DESIGN FOR MAGNETIC RESONANCE FINGERPRINTING WITH B-SPLINES | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | TCHATCHOUANG, CARL F.R. | §101§112 | Non-Final OA | — | Pending | Oct 28, 2024 | |
| 18856984 | DEVICE, SYSTEM, AND METHOD FOR TISSUE IDENTIFICATION DURING ROBOTIC SURGERY | The Regents of the University of California | SCHERBEL, TODD J | 3792 | §102§112 | Non-Final OA | — | Pending | Oct 15, 2024 |
| 18904575 | Compositions and Methods for Targeting Lipid Nanoparticle Therapeutics to Stem Cells | The Trustees of the University of Pennsylvania | WESTERBERG, NISSA M | 1618 | §103Other | Non-Final OA | 18d overdue | Pending | Oct 02, 2024 |
| 18848241 | DEVICES AND METHODS FOR RAPID BIOSENSING | New York University | SANGHERA, JAS A | 2852 | §102§103§112 | Non-Final OA | — | Pending | Sep 18, 2024 |
| 18820570 | PULSED FIELD ABLATION DEVICE AND METHOD | Btl Medical Development A.S. | PEFFLEY, MICHAEL F | §102§103 | Non-Final OA | — | Pending | Aug 30, 2024 | |
| 18793238 | METHODS AND COMPOSITIONS FOR TREATING LIVER DISEASE | Temple University-Of The Commonwealth System Of Higher Education | ROBINSON, MIKHAIL O'DONNEL | §102§103 | Non-Final OA | — | Pending | Aug 02, 2024 | |
| 18725671 | Immobilized Enzyme and Application thereof in Continuous Production | Asymchem Life Science (Tianjin) Co., Ltd. | SAIDHA, TEKCHAND | §112 | Non-Final OA | — | Pending | Jun 28, 2024 | |
| 18721326 | COMPOSITIONS AND METHODS FOR DELIVERY OF IL-2 AND ANTI-IL-2 FOR TREATMENT OF RHEUMATOID ARTHRITIS | Arizona Board of Regents | SCHLIENTZ, NATHAN W | 1616 | §103§112 | Non-Final OA | — | Pending | Jun 18, 2024 |
| 18719518 | METHOD FOR PREPARING HIGHLY DIFFERENTIATED KIDNEY ORGANOIDS | Rgenorgano Biotechnology Co., Ltd. | SMITH, ADAM MICHAEL | §103§112 | Non-Final OA | — | Pending | Jun 13, 2024 | |
| 18673924 | SYSTEM AND METHOD OF POSE DETECTION | Accompaneed LLC | FUJITA, KATRINA R | 2672 | §101§112 | Non-Final OA | 20d | Pending | May 24, 2024 |
| 18658276 | EXTRAMAMMARY PAGET DISEASE BIOMARKERS AND USES THEREOF | The Catholic University Of Korea Industry-Academic Cooperation Foundation | BOWERS, ERIN M | 1653 | §101§103§112 | Non-Final OA | — | Pending | May 08, 2024 |
| 18703591 | COMPOSITION FOR AMELIORATING HAIR LOSS COMPRISING BOTULINUM-DERIVED PEPTIDE | BPMED CO., LTD. | IANNUZO, NATALIE NMN | 1653 | §103 | Non-Final OA | 72d | Pending | Apr 22, 2024 |
| 18640327 | PREDICTIVE MAINTENANCE ALGORITHM PROVIDING METHOD FOR BUS MAINTENANCE PRIORITY DETERMINATION | Korea Transportation Safety Authority | CLARE, MARK C | 3628 | §101 | Non-Final OA | — | Pending | Apr 19, 2024 |
| 18701320 | METHODS AND SYSTEMS FOR PROCESSING AND FORMULATING PLANT MATERIAL | Flowerpod, LLC | PACKARD, BENJAMIN J | 1612 | §102§103§112 | Non-Final OA | 42d | Pending | Apr 15, 2024 |
| 18633750 | SYSTEM AND METHOD FOR GENERATING VIDEOS DEPICTING VIRTUAL CHARACTERS | UNIVERSITY OF ROCHESTER | LE, MICHAEL | 2614 | §103 | Non-Final OA | 19d overdue | Pending | Apr 12, 2024 |
| 18699081 | Novel Immune Cell Engagers For Immunotherapy | The Wistar Institute | GURLEY, JAMI MICHELLE | §102§103§112 | Non-Final OA | — | Pending | Apr 05, 2024 | |
| 18609070 | Use of Short Chain Fatty Acids in Cancer Prevention | Temple University-Of The Commonwealth System Of Higher Education | PYLA, EVELYN Y | 1633 | §101§102§103 | Non-Final OA | 2d overdue | Pending | Mar 19, 2024 |
| 18689656 | Universal Influenza Vaccine and Methods of Use | The Trustees of the University of Pennsylvania | ZOU, NIANXIANG | §102§103§112 | Non-Final OA | — | Pending | Mar 06, 2024 | |
| 18593283 | ANGLE-ADJUSTABLE RATCHET TOOL | Thomas Jefferson University | CHUKWURAH, NATHANIEL C | 3723 | §103 | Non-Final OA | — | Pending | Mar 01, 2024 |
| 18590310 | SYSTEM AND METHOD FOR UNMANNED AERIAL SIGNAL RELAY | Dragonfly Pictures, Inc. | LEITE, PAULO ROBERTO GONZ | 3663 | §103 | Non-Final OA | 9d | Pending | Feb 28, 2024 |
| 18588643 | MAGE-A VACCINES AND METHODS OF TREATMENT USING THE SAME | The Wistar Institute | EDGINGTONGIORDANO, FRANCESCA | 1643 | §101§102§112Other | Non-Final OA | 37d overdue | Pending | Feb 27, 2024 |
| 18431444 | ROLLINGCACHE: USING RUNTIME BEHAVIOR TO DEFEND AGAINST CACHE SIDE CHANNEL ATTACKS | UNIVERSITY OF ROCHESTER | LIU, ZHE | 2493 | §103§112 | Non-Final OA | — | Pending | Feb 02, 2024 |
| 18293146 | Esterase Mutant and Use thereof | Asymchem Laboratories (Tianjin) Co., Ltd. | MOEHLMAN, ANDREW TERRY | 1655 | §102§112 | Non-Final OA | — | Pending | Jan 29, 2024 |
| 18291968 | Methods and Apparatuses for Wearable Neuromodulation Pain Relief Device | Muonx, LLC | KOHUTKA, BROOKE NICOLE | §101§102§103§112 | Non-Final OA | — | Pending | Jan 25, 2024 | |
| 18411673 | METHODS AND DEVICES FOR AESTHETIC TREATMENT OF BIOLOGICAL STRUCTURES BY RADIOFREQUENCY AND MAGNETIC ENERGY | Btl Medical Solutions A.S. | LANNU, JOSHUA DARYL DEANON | §103§112Other | Non-Final OA | — | Pending | Jan 12, 2024 | |
| 18407958 | Extreme Polyvalency Induces Potent Cross-Clade Cellular and Humoral Responses in Rabbits and Non-human Primates | The Wistar Institute | LI, BAO Q | 1671 | §102§103§112 | Non-Final OA | 40d | Pending | Jan 09, 2024 |
| 18577390 | FORMULATIONS FOR THE TREATMENT OF RESPIRATORY DISORDERS | 484 Science Corp. | HOLLOMAN, NANNETTE | 1612 | §102§103§112 | Non-Final OA | 40d | Pending | Jan 08, 2024 |
| 18405123 | Labral Anchor System and Method | Aevumed, Inc. | DAVID, SHAUN L | 3771 | §103 | Final Rejection | 23d overdue | Pending | Jan 05, 2024 |
| 18576830 | VCP INHIBITORS AND USES THEREOF FOR TREATMENT | The Francis Crick Institute Limited | CHONG, YONG SOO | 1623 | §102§103§112 | Non-Final OA | — | Pending | Jan 05, 2024 |
| 18539995 | Persistent Luminescent Nanoparticle and Articles Comprising the Same | Thomas Jefferson University | KOSLOW, CAROL M | 1734 | §112 | Final Rejection | 31d overdue | Pending | Dec 14, 2023 |
| 18569842 | MORPHABLE BONE FIXATION DEVICE, SYSTEM AND METHOD | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | JOHANAS, JACQUELINE T | 3773 | §102§103§112 | Final Rejection | 22d | Pending | Dec 13, 2023 |
| 18566859 | SYNTHETIC DNA VACCINE IMMUNOGENIC IMPROVEMENTS | The Wistar Institute | WANG, RUIXUE | 1672 | §101§102§103§112 | Non-Final OA | — | Pending | Dec 04, 2023 |
| 18517137 | PEER-BASED AUDITING SYSTEM AND METHOD | Novadata Solutions LLC | CHAMPAGNE, LUNA | 3627 | §101§103 | Final Rejection | 16d | Pending | Nov 22, 2023 |
| 18515486 | COMPOSITION FOR INHIBITING SKIN PIGMENTATION THROUGH AUTOPHAGY ACTIVITY CONTAINING PROCYANIDIN A2 AND QUERCETIN, AS ACTIVE INGREDIENTS | Kyungpook National University Industry-Academic Cooperation Foundation | MAYHEW, BRADLEY SCOTT | 1621 | §103 | Non-Final OA | — | Pending | Nov 21, 2023 |
| 18515636 | MonoMac-1 Cells Expressing CD16 and CD163 | Temple University-Of The Commonwealth System Of Higher Education | BUNNER, BRIDGET E | 1647 | §102§112 | Non-Final OA | — | Pending | Nov 21, 2023 |
| 18512727 | 3D PRINTED SCAFFOLDS FOR USE IN TISSUE REPAIR | Aevumed, Inc. | STRANSKY, KATRINA MARIE | 3700 | §102§103 | Non-Final OA | 2d overdue | Pending | Nov 17, 2023 |
| 18508879 | Smart Wearable IOT Device for Health Tracking, Contact Tracing and Prediction of Health Deterioration | New York University | HUSSAINI, ATTIYA SAYYADA | 3792 | §102§103§112 | Non-Final OA | — | Pending | Nov 14, 2023 |
| 18503487 | Vaccines For Human Papilloma Virus And Methods For Using The Same | Inovio Pharmaceuticals, Inc. | ZOU, NIANXIANG | 1671 | DP | Non-Final OA | 138d overdue | Pending | Nov 07, 2023 |
| 18557729 | COMPOSITION FOR PREVENTING OR TREATING MUSCULAR DISEASE, COMPRISING OXICAM-BASED COMPOUND | Animuscure Inc. | NEAGU, IRINA | 1629 | §102§103§112 | Non-Final OA | — | Pending | Oct 27, 2023 |
| 18557654 | MACOLACINS AND METHODS OF USE THEREOF | The Rockefeller University | VARADARAJ, ARCHANA | 1653 | §103 | Non-Final OA | — | Pending | Oct 27, 2023 |
| 18556746 | COMPOSITION FOR PREVENTING OR TREATING DISEASES CAUSED BY MITOCHONDRIAL DYSFUNCTION, CONTAINING ISOQUINOLINE DERIVATIVE COMPOUND AS ACTIVE INGREDIENT | Altmedicalco., Ltd. | HABTE, KAHSAY | 1624 | DP | Final Rejection | 13d | Pending | Oct 23, 2023 |
| 18556414 | GLYCAN MODIFIED SPIKE RECEPTOR BINDING DOMAIN NANOPARTICLES AND METHOD OF USE THEREOF AS A CORONAVIRUS DISEASE 2019 (COVID-19) VACCINE | The Wistar Institute | BOESEN, AGNIESZKA | 1672 | §102§112DP | Non-Final OA | 84d | Pending | Oct 20, 2023 |
| 18486265 | DEVICE, SYSTEM AND METHOD FOR CONTINUOUS ESTIMATION OF ORGAN AND TISSUE SIZE AND CONTENT WITHIN AN INTACT ORGANISM | Yale University | YOON, CHANEL J | 3791 | §103§112 | Non-Final OA | — | Pending | Oct 13, 2023 |
| 18479174 | APPARATUS, SYSTEM AND METHOD FOR PLUG CLEARING IN AN ADDITIVE MANUFACTURING PRINT HEAD | 3D Print Innovations, LLC | WOO, JONATHAN BRIAN | 1754 | §103 | Non-Final OA | 14d | Pending | Oct 02, 2023 |
| 18552635 | DNA Encoded Nanoparticle Vaccine Against Human Papillomavirus, and Methods of Use Thereof | The Wistar Institute | CORNELIUS, CLAIRE ADRIENNE | 1672 | §101§102§103§112 | Non-Final OA | — | Pending | Sep 26, 2023 |
| 18471355 | METHODS AND COMPOSITIONS FOR TREATING CANCERS USING ANTISENSE | Thomas Jefferson University | CHONG, KIMBERLY | 1636 | §103§112Other | Non-Final OA | — | Pending | Sep 21, 2023 |
| 18467202 | SYSTEM AND METHOD FOR AUTONOMOUS CHARGING | New York University | OMAR, AHMED H | §102§103 | Non-Final OA | — | Pending | Sep 14, 2023 | |
| 18549948 | Noninvasive AAV Vectors For Highly Efficient Gene Delivery To The Nervous System | Temple University-Of The Commonwealth System Of Higher Education | HUMPHRIES, NICHOLAS ADAM | 1631 | §102§103§112 | Non-Final OA | — | Pending | Sep 11, 2023 |
| 18459209 | MULTI-ARMED MYXOMA VIRUS | Arizona Board Of Regents For And On Behalf Of Arizona State University | MONTANARI, DAVID A | 1632 | §103 | Non-Final OA | — | Pending | Aug 31, 2023 |
| 18458214 | Recombinant Fusion Proteins Targeting P-selectin, and Methods of Use Thereof for Treating Diseases and Disorders | UNIVERSITAT DE BARCELONA | ALLEN, MARIANNE P | 1647 | §102§103§112Other | Non-Final OA | 104d overdue | Pending | Aug 30, 2023 |
| 18455834 | MOTION-ACTIVATED, CLOSED-LOOP NON-INVASIVE VAGUS NERVE STIMULATION FOR NEUROREHABILITATION | Musc Foundation For Research Development | EDWARDS, PHILIP CHARLES | 3792 | §101§103 | Final Rejection | — | Pending | Aug 25, 2023 |
| 18450169 | APPARATUS, SYSTEM AND METHOD FOR ULTRASONIC-BASED ADDITIVE MANUFACTURING | 3D Print Innovations LLC | HEMINGWAY, TIMOTHY G | 1754 | §103§112 | Non-Final OA | 4d overdue | Pending | Aug 15, 2023 |
| 18449091 | DEVICE, SYSTEM AND METHOD FOR MONITORING NEUROLOGICAL FUNCTIONAL STATUS | Musc Foundation For Research Development | CERIONI, DANIEL LEE | 3791 | §103 | Final Rejection | 56d overdue | Pending | Aug 14, 2023 |
| 18365369 | Method for Determining Prognosis of Cancer | Queen Mary University Of London | AEDER, SEAN E | 1642 | §101 | Non-Final OA | 3d overdue | Pending | Aug 04, 2023 |
| 18360140 | SYSTEM AND METHOD FOR NEURAL NETWORK MULTIPLE TASK ADAPTATION | Arizona Board of Regents | WASAFF, JOHN S. | 3629 | §103 | Final Rejection | — | Pending | Jul 27, 2023 |
| 18359521 | EXOSUIT DEVICE AND METHOD FOR EXOSUIT MODELING AND DESIGN | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | MILLER, DANIEL A | 3786 | §103§112 | Non-Final OA | 5d | Pending | Jul 26, 2023 |
| 18342930 | LUNG CANCER MODELING USING NORMAL LUNG ORGANOID WITH LUNG CANCER CELLS | The Catholic University Of Korea Industry-Academic Cooperation Foundation | CANDELARIA, JULIANA IRENE | 1634 | §103 | Final Rejection | 14d | Pending | Jun 28, 2023 |
| 18256143 | IMMUNE CHECKPOINT INHIBITOR CONJUGATED WITH ULTRASONIC SENSITIZER, AND USE THEREOF | Imgt Co., Ltd. | TAYLOR, LIA ELAN | 1641 | §102§103 | Non-Final OA | — | Pending | Jun 06, 2023 |
| 18254052 | COMPOSITION FOR PREPARING DECELLULARIZED SCAFFOLD, COMPRISING GRAPHENE NANOSTRUCTURE | BIOGO CO., LTD. | WOZNICKI, JACQUELINE | 3774 | §103§112 | Final Rejection | 16d | Pending | May 23, 2023 |
| 18253520 | ALGORITHMS FOR PREDICTING VUG CONNECTIVITY | UNIVERSITY OF KANSAS | KIM, EUNHEE | §102§103§112 | Non-Final OA | — | Pending | May 18, 2023 | |
| 18253250 | TARGETING HOST-BACTERIA INTERACTIONS FOR THE TREATMENT OF MICROBIOTA-MEDIATED DISEASES | Yale University | GROSS, CHRISTOPHER M | 1684 | §102§112 | Non-Final OA | — | Pending | May 17, 2023 |
| 18252301 | SMART SYRINGE DEVICE, SYSTEM AND METHOD | The Regents of the University of California | WINAKUR, ERIC FRANK | 3791 | §103§112 | Non-Final OA | — | Pending | May 09, 2023 |
| 18312793 | SYSTEM AND METHOD FOR REMOVING CARBON DIOXIDE FROM SEA WATER | Yale University | KEYWORTH, PETER | 1777 | §112 | Non-Final OA | — | Pending | May 05, 2023 |
| 18251620 | DNA ENCODED NANOPARTICLES AND METHOD OF USE THEREOF AS A CORONAVIRUS DISEASE 2019 (COVID-19) VACCINE | The Wistar Institute | GILL, RACHEL B | 1671 | §101§102§112Other | Non-Final OA | 11d overdue | Pending | May 03, 2023 |
| 18134886 | NANOSCALE PROCESS TO GENERATE REAGENTS SELECTIVE FOR INDIVIDUAL PROTEIN VARIANTS | Arizona Board of Regents | DRISCOLL, LORA E BARNHART | 3991 | §112Other | Non-Final OA | — | Pending | Apr 14, 2023 |
| 18299324 | Reverse Transcriptase and Methods of Use | Yale University | KANE, TREVOR LOGAN | 1657 | DP | Final Rejection | — | Pending | Apr 12, 2023 |
| 18248648 | COMPOSITION FOR PREVENTING OR TREATING NEUROMUSCULAR DISEASE, COMPRISING PRMT1 PROTEIN OR GENE ENCODING SAME | Animuscure Inc. | DAVIS, RUTH A | 1699 | §103§112 | Final Rejection | 70d | Pending | Apr 11, 2023 |
| 18248166 | METHOD FOR DETERMINING WHETHER OR NOT VIRUS-NEUTRALIZING ANTIBODIES ARE PRESENT AND IN VITRO METHOD FOR SCREENING COMPOUNDS FOR THEIR ABILITY TO NEUTRALIZE A VIRUS | Eximmium Biotechnologies GmbH | GRIZER, CASSANDRA SENN | 1672 | §101§102§103§112 | Final Rejection | 84d overdue | Pending | Apr 06, 2023 |
| 18248080 | UNIVERSAL RIBOSWITCH FOR INDUCIBLE GENE EXPRESSION | Wageningen Universiteit | REGA, KYLE THOMAS | 1636 | §102§103 | Non-Final OA | — | Pending | Apr 06, 2023 |
| 18247155 | JOINT DISTRACTION DEVICE | New York University | HANNA, SAMUEL SALEEB | 3775 | §102§103§112 | Final Rejection | 10d overdue | Pending | Mar 29, 2023 |
| 18190466 | DEVICE FOR REPETITIVE NERVE STIMULATION IN ORDER TO BREAK DOWN FAT TISSUE MEANS OF INDUCTIVE MAGNETIC FIELDS | Btl Medical Solutions A.S. | MATTHEWS, CHRISTINE HOPKINS | 3791 | §101§103§112 | Non-Final OA | — | Pending | Mar 27, 2023 |
| 18042796 | INTRADERMAL MERS-CoV VACCINE | The Wistar Institute | GILL, RACHEL B | 1671 | §103§112Other | Non-Final OA | 12d | Pending | Feb 24, 2023 |
| 18042385 | Nanobody Compositions and Methods of Use of the Same | Yale University | FLINDERS, JEREMY C | 1684 | §101§102§112DP | Non-Final OA | — | Pending | Feb 21, 2023 |
| 18040318 | MRNA VACCINE COMPRISING ADJUVANT CAPABLE OF KINETIC CONTROL | Progeneer Inc. | ALLEN, SARAH ELIZABETH | 1637 | §103§112DP | Final Rejection | — | Pending | Feb 02, 2023 |
| 18040328 | KINETICALLY ACTING ADJUVANT ENSEMBLE | Progeneer Inc. | ROSSI, JULIA ANNE LORRAIN | 1615 | §103§112 | Non-Final OA | — | Pending | Feb 02, 2023 |
| 18158768 | Biomarkers for identifying e-cigarette, or vaping, product use-associated lung injury | UNIVERSITY OF ROCHESTER | COUNTS, GARY W | 1678 | §101§102§103§112 | Non-Final OA | 9d overdue | Pending | Jan 24, 2023 |
| 18006590 | RAPID CLINICAL TEST FOR GENETIC DIAGNOSIS INVOLVING KNOWN VARIANTS | Yale University | BAUSCH, SARAE L | 1699 | §102§103 | Non-Final OA | — | Pending | Jan 24, 2023 |
| 18006321 | LIQUID CRYSTAL SCAFFOLDS AND USE THEREOF | Amir Nasajpour | SCHUBERG, LAURA J | 1631 | §102§103 | Final Rejection | 37d overdue | Pending | Jan 20, 2023 |
| 18004964 | DNA ANTIBODY CONSTRUCTS FOR USE AGAINST ROTAVIRUS | The Wistar Institute | BUCKMASTER, MARLENE VRENI | 1672 | §102§103§112 | Final Rejection | — | Pending | Jan 10, 2023 |
| 18002951 | Use of Caveolin-1 Scaffolding Domain Peptides for Treating Disease and Disorders | Musc Foundation For Research Development | DABKOWSKI, ERINNE R | 1654 | §103§112 | Final Rejection | — | Pending | Dec 22, 2022 |
| 18002995 | System and Method for Detection of Biomolecules in Tissues, Organs, and Extracellular Fluid | The Regents of the University of California | JANG, CHRISTIAN Y | 3791 | §102§103 | Final Rejection | — | Pending | Dec 22, 2022 |
| 18002125 | Containment, Treatment, and Removal of Aerosolized Viral Contamination | Aeragen, Inc. | LANNU, JOSHUA DARYL DEANON | 3791 | §103 | Final Rejection | 20d | Pending | Dec 16, 2022 |
| 18064482 | LARGE AND SMALL T ANTIGENS OF MERKEL CELL POLYOMAVIRUS, NUCLEIC ACID CONSTRUCTS AND VACCINES MADE THEREFROM, AND METHODS OF USING SAME | The Wistar Institute | FOLEY, SHANON A | 1671 | §102§112Other | Non-Final OA | 138d overdue | Pending | Dec 12, 2022 |
| 18000531 | Monoclonal Antibody Against Human Siglec-9 and Use For Immunotherapy | David Weiner | JUEDES, AMY E | 1644 | §112Other | Final Rejection | 88d overdue | Pending | Dec 02, 2022 |
| 18059476 | Gradient Structures Interfacing Microfluidics and Nanofluidics, Methods for Fabrication and Uses Thereof | Princeton University | SIEFKE, SAMUEL P | 1758 | §112Other | Non-Final OA | 31d overdue | Pending | Nov 29, 2022 |
| 18059196 | SYSTEM AND METHODS FOR INCREASING SYNTHESIZED PROTEIN STABILITY | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | LUO, JAMMY NMN | 1686 | §101§103§112 | Non-Final OA | — | Pending | Nov 28, 2022 |
| 18000011 | NONINVASIVE CRANIAL NERVE THERAPY | Musc Foundation For Research Development | WEBSTER, KARMEL JOHANNA | 3792 | §103 | Final Rejection | 52d overdue | Pending | Nov 28, 2022 |
| 17998170 | Polymer Composites and Methods of Making the Same | Temple University-Of The Commonwealth Systemof Higher Education | JOHNSON, JENNA LEIGH | 1789 | §103 | Final Rejection | 70d overdue | Pending | Nov 08, 2022 |
| 17997963 | DNA ANTIBODY CONSTRUCTS FOR USE AGAINST HEPATITIS B VIRUS | The Wistar Institute | XIAO, YAN | 1642 | §112 | Final Rejection | 28d | Pending | Nov 04, 2022 |
| 17997572 | Epiprinter Technology and Methods of Use for Detecting Biomolecules | Temple University-Of The Commonwealth System Of Higher Education | BAUSCH, SARAE L | 1699 | §101§102§103§112 | Final Rejection | — | Pending | Oct 31, 2022 |
| 17996119 | CORONAVIRUS VACCINE COMPOSITIONS AND METHODS OF USE | Thomas Jefferson University | SALVOZA, M FRANCO G | 1672 | §103§112Other | Non-Final OA | 30d overdue | Pending | Oct 13, 2022 |
| 18045575 | TERT IMMUNOGENIC COMPOSITIONS AND METHODS OF TREATMENT USING THE SAME | Inovio Pharmaceuticals, Inc. | ALAWADI, SARAH | 1619 | §102Other | Final Rejection | 34d | Pending | Oct 11, 2022 |
| 17907703 | ANTI-FUNGAL POLYPEPTIDES | BIOTALYS NV | SHARMA, SANTOSH | 1663 | §102§112DPOther | Non-Final OA | — | Pending | Sep 29, 2022 |
| 17907697 | Synthetic Soluble Receptor Mimics and Methods of Use for Treatment of COVID-19 | The Wistar Institute | ROSSI, JULIA ANNE LORRAIN | 1615 | §102§103§112 | Non-Final OA | 167d overdue | Pending | Sep 29, 2022 |
| 17907156 | CRISPR-Cas13 crRNA Arrays | UNIVERSITY OF ROCHESTER | REGA, KYLE THOMAS | 1636 | §103Other | Non-Final OA | — | Pending | Sep 23, 2022 |
| 17907121 | Targeted Destruction of Viral RNA by CRISPR-Cas13 | UNIVERSITY OF ROCHESTER | HILL, KEVIN KAI | 1638 | §103§112 | Non-Final OA | 145d overdue | Pending | Sep 23, 2022 |
| 17906763 | COMPOSITION AND KIT FOR REMOVING LIPOPOLYSACCHARIDE | Hlb Science Inc. | MARTINEZ, TARA L | 1654 | §102§103§112Other | Non-Final OA | 13d | Pending | Sep 20, 2022 |
| 17906694 | Preparation of Cerium (III) Carbonate Dispersion | Rohm And Haas Company | QUIST, NICOLE LEE | 1738 | §102§103 | Final Rejection | 23d overdue | Pending | Sep 19, 2022 |
| 17941159 | HAND-HELD RADAR SYSTEM TO MEASURE INTRAOCULAR PRESSURE AND TO ASSESS EYE DISEASES AND METHOD THEREFOR | Natural Eye Care, Inc. | KREMER, MATTHEW | 3791 | §103§112 | Final Rejection | 15d | Pending | Sep 09, 2022 |
| 17905894 | Cyclic Peptides | Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts Universitatsmedizin | CARTER, SANDRA DILLAHUNT | 1674 | §102§112 | Non-Final OA | — | Pending | Sep 08, 2022 |
| 17817696 | METHOD OF DIAGNOSIS, PROGNOSIS, AND TREATMENT OF VITAMIN D DEFICIENCY AND VITAMIN D IMBALANCE AND DISEASES AND DISORDERS ASSOCIATED THEREOF | Temple University-Of The Commonwealth System Of Higher Education | TURK, NEIL N | 1798 | §101§112 | Final Rejection | 69d | Pending | Aug 05, 2022 |
| 17760213 | Ribozyme-mediated RNA Assembly and Expression | UNIVERSITY OF ROCHESTER | MCKILLOP, JOHN CHARLES | 1637 | §103DP | Final Rejection | — | Pending | Aug 05, 2022 |
| 17816152 | Tumor-on-a-chip | New York University | MYERS, CARLA J | 1682 | §112 | Final Rejection | — | Pending | Jul 29, 2022 |
| 17759649 | CD40-L BLOCKADE TO ENHANCE SYNTHETIC ANTIBODY THERAPY | The Wistar Institute | BUNNER, BRIDGET E | 1647 | §102 | Non-Final OA | — | Pending | Jul 28, 2022 |
| 17759220 | GRAPHENE-BASED COMPOSITION FOR TREATING KIDNEY DISEASE | Seoul National University R & Db Foundation | ALAWADI, SARAH | 1619 | §102§103 | Final Rejection | — | Pending | Jul 21, 2022 |
| 17813717 | VACUUM INFUSION MACHINE AND VACUUM INFUSION METHOD | Bkon LLC | AXTELL, ASHLEY | 1792 | §103§112 | Non-Final OA | — | Pending | Jul 20, 2022 |
| 17813762 | CANCER VACCINES AND METHODS OF TREATMENT USING THE SAME | Inovio Pharmaceuticals, Inc. | SALVOZA, M FRANCO G | 1672 | Other | Non-Final OA | 28d | Pending | Jul 20, 2022 |
| 17813395 | INTEGRATED CIRCUIT WITH TOPOLOGICAL SEMIMETAL INTERCONNECTS | Yale University | DUMBRIS, SETH M | 1784 | §103 | Final Rejection | 34d | Pending | Jul 19, 2022 |
| 17845461 | COMPOSITION AND METHODS FOR CULTURING RETINAL PROGENITOR CELLS | Yale University | MOLOYE, TITILAYO | 1632 | §103 | Final Rejection | 36d overdue | Pending | Jun 21, 2022 |
| 17787729 | VACCINES AGAINST AFRICAN SWINE FEVER VIRUS, AND METHODS OF USING SAME | The Wistar Institute | SIFFORD, JEFFREY MARK | 1671 | §101§102§103§112DP | Non-Final OA | — | Pending | Jun 21, 2022 |
| 17842225 | METHODS FOR TREATING EYE DISEASE | The United States Department of Veterans Affairs | VIVLEMORE, TRACY ANN | 1638 | §103 | Final Rejection | 28d overdue | Pending | Jun 16, 2022 |
| 17782338 | A T cell-based immunotherapy for central nervous system viral infections and tumors | Yale University | ALSOMAIRY, SARAH ABDOALATIF | 1646 | §103Other | Final Rejection | 15d | Pending | Jun 03, 2022 |
| 17781823 | Co-immobilized enzyme, preparation method and use thereof | Jilin Asymchem Laboratories Co., Ltd. | IANNUZO, NATALIE NMN | 1653 | §103§112 | Non-Final OA | — | Pending | Jun 02, 2022 |
| 17750848 | NOVEL METHODS OF TREATING A NEURODEGENERATIVE DISEASE IN A MAMMAL IN NEED THEREOF | Thomas Jefferson University | SHOWALTER, ALEXANDER KEITH | 1629 | §112DP | Final Rejection | — | Pending | May 23, 2022 |
| 17772660 | Continuous synthesis method for ethoxymethylenemalononitrile | Asymchem Laboratories (Tianjin) Co., Ltd. | CHENG, KAREN | 1623 | §103 | Non-Final OA | — | Pending | Apr 28, 2022 |
| 17771320 | Vaginal Drug Delivery Device | The Regents of the University of California | LAZARO, DOMINIC | 1611 | §103§112 | Non-Final OA | 30d overdue | Pending | Apr 22, 2022 |
| 17769686 | Bio-Zipper Surgical Closure Device | The Regents of the University of California | MENDEZ, KATHERINE H | 3771 | §103§112 | Non-Final OA | 31d overdue | Pending | Apr 15, 2022 |
| 17767856 | ONCOLYTIC VIRUSES THAT EXPRESS MULTI-SPECIFIC IMMUNE CELL ENGAGERS | Arizona Board of Regents | VIVLEMORE, TRACY ANN | 1638 | §103§112 | Non-Final OA | — | Pending | Apr 08, 2022 |
| 17637100 | PORTABLE AND COMPACT SYSTEM FOR DELIVERY OF HUMIDIFIED HIGH FLOW NASAL CANNULA (HHFNC) THERAPY IN NEONATES AND INFANTS | Yale University | KHONG, BRIAN THAI-BINH | 3700 | §112 | Final Rejection | — | Pending | Feb 22, 2022 |
| 17636209 | Metabolic Reprogramming of Immune Cells for the Treatment or Prevention of Diseases and Disorders | Arizona Board of Regents | NGUYEN, JOHN P | 1619 | §103Other | Non-Final OA | 19d overdue | Pending | Feb 17, 2022 |
| 17592169 | BIOMIMETIC TISSUE AND METHOD OF USE THEREOF | New York University | ARNOLD, ERNST V | 1613 | §103 | Non-Final OA | 36d overdue | Pending | Feb 03, 2022 |
| 17628913 | Targeted RNA cleavage with CRISPR-Cas | UNIVERSITY OF ROCHESTER | SPENCER, ANDREA LYNNE MORRIS | 1631 | §102§103§112 | Final Rejection | 20d | Pending | Jan 21, 2022 |
| 17627612 | SYSTEM AND METHOD FOR MEASURING TISSUE PARAMETERS BY USE OF CAPACITIVE TACTILE SENSOR | UE LifeSciences Inc. | XU, JUSTIN | 3791 | §103 | Final Rejection | 14d | Pending | Jan 14, 2022 |
| 17626903 | Genetically Modified Non-Human Animals and Methods of Use Thereof | Yale University | SINGH, ANOOP KUMAR | 1632 | §103§112 | Non-Final OA | — | Pending | Jan 13, 2022 |
| 17618390 | OSTEOINDUCTIVE MODIFIED GELATIN HYDROGELS AND METHODS OF MAKING AND USING THE SAME | The Regents of the University of California | ALAM, AYAAN A | 1611 | §103§112 | Non-Final OA | — | Pending | Dec 10, 2021 |
| 17541154 | NON-INVASIVE PROPRIOCEPTIVE STIMULATION FOR TREATING EPILEPSY | The Regents of the University of California | MILLER, CHRISTOPHER E | 3785 | §103 | Non-Final OA | 38d overdue | Pending | Dec 02, 2021 |
| 17534718 | NON-CONTACT CELL MANIPULATION SYSTEM, DEVICE AND METHOD | New York University In Abu Dhabi Corporation | HASSAN, LIBAN M | 1799 | §112 | Non-Final OA | 69d | Pending | Nov 24, 2021 |
| 17611758 | Metabolite Delivery for Modulating Metabolic Pathways of Cells | Arizona Board of Regents | PUTTLITZ, KARL J | 1646 | §103 | Final Rejection | — | Pending | Nov 16, 2021 |
| 17499777 | METHODS FOR DETECTING TRAUMATIC BRAIN INJURY | Arizona Board of Regents | BALLARD, KIMBERLY | 1675 | §112 | Non-Final OA | — | Pending | Oct 12, 2021 |
| 17599023 | METHODS FOR TREATING CANCERS USING ANTISENSE | Thomas Jefferson University | PERSONS, JENNA L | 1637 | §103§112DP | Final Rejection | — | Pending | Sep 28, 2021 |
| 15733794 | NONWOVEN HEMP HURD-BASED MATERIALS | Thomas Jefferson University | SINGH-PANDEY, ARTI R | 1759 | §102§103§112 | Non-Final OA | 50d overdue | Pending | Sep 23, 2021 |
| 17432658 | Methods of modulating immune response | Garvan Institute Of Medical Research | SULLIVAN, STEPHANIE LAUREN | 1635 | §101§102§103§112 | Non-Final OA | 20d | Pending | Aug 20, 2021 |
| 17427434 | DNA-ENCODED BISPECIFIC T-CELL ENGAGERS TARGETING CANCER ANTIGENS AND METHODS OF USE IN CANCER THERAPUTICS | The Wistar Institute | CUNNINGCHEN, KATHLEEN MARY | 1646 | §102§103§112DP | Final Rejection | — | Pending | Jul 30, 2021 |
| 17425384 | NOVEL BIOMARKERS AND DIAGNOSTIC PROFILES FOR PROSTATE CANCER | UEA Enterprises Limited | CLOW, LORI A | 1687 | §101§103§112 | Non-Final OA | 66d overdue | Pending | Jul 23, 2021 |
| 17371613 | GRAPHITIC CARBON NITRIDE MATERIALS AND METHODS OF MAKING AND USE THEREOF | New York University | ALEJANDRO, RAYMOND | 1752 | §103 | Final Rejection | 28d | Pending | Jul 09, 2021 |
| 17317057 | DETECTION OF AUTOREACTIVE FECAL IMMUNOGLOBULIN A (IGA) FOR DIAGNOSIS OF LUPUS | Musc Foundation For Research Development | BALLARD, KIMBERLY | 1675 | §103 | Final Rejection | 34d | Pending | May 11, 2021 |
| 17290797 | METHODS AND COMPOSITIONS FOR TREATING HEPATOCELLULAR CARCINOMA USING ANTISENSE | Thomas Jefferson University | VAN DRUFF, SYDNEY | 1643 | §103Other | Final Rejection | 6d | Pending | May 03, 2021 |
| 17287184 | Genome Editing by Directed Non-Homologous DNA Insertion Using a Retroviral Integrase-Cas9 Fusion Protein | UNIVERSITY OF ROCHESTER | HASAN, KHALEDA B | 1636 | §103Other | Non-Final OA | 42d | Pending | Apr 21, 2021 |
| 17283315 | Selective Binding and Aggregation of Human Keratin in the Skin Barrier Using Human Filaggrin Subdomains SD67 and SD150 | Yale University | DABKOWSKI, ERINNE R | 1654 | §112 | Final Rejection | 57d | Pending | Apr 07, 2021 |
| 17268635 | PHARMACEUTICAL COMPOSITION FOR TREATING CARTILAGE DAMAGE, COMPRISING NASAL SEPTUM CHONDROCYTES | The Catholic University Of Korea Industry-Academic Cooperation Foundation | RIGA, MICHAEL ANGELO | 1634 | §103 | Final Rejection | — | Pending | Feb 16, 2021 |
| 16973603 | COMPOSITIONS AND METHODS FOR IN VIVO POST TRANSLATIONAL MODIFICATION | The Wistar Institute | POPA, ILEANA | 1633 | §112 | Non-Final OA | 17d overdue | Pending | Dec 09, 2020 |
| 17046829 | CLASSIFICATION AND PROGNOSIS OF PROSTATE CANCER | UEA Enterprises Limited | LEVERETT, MARY CHANG | 1687 | §101 | Final Rejection | — | Pending | Oct 12, 2020 |
| 16755198 | A Cell-Based Seeding Assay for Huntingtin Aggregation | The Regents of the University of California | BALLARD, KIMBERLY | 1675 | §103 | Final Rejection | 20d | Pending | Apr 10, 2020 |
| 16347861 | DNA ANTIBODY CONSTRUCTS FOR USE AGAINST LYME DISEASE | The Wistar Institute | ZEMAN, ROBERT A | 1645 | §112 | Non-Final OA | 10d overdue | Pending | May 07, 2019 |
| 15548197 | INTEGRATED PAINLESS BONE MARROW BIOPSY DEVICE | Yale University | CATINA, MICHAEL ANTHONY | 3791 | §103 | Final Rejection | 30d | Pending | Aug 02, 2017 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial